Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 3 holding rows worth $131,016,000.

Accession
0000919574-14-003157
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 3 entries on the cover page, a total value of $131,016,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $131,016,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Synta Pharmaceuticals Corp.87162T206COM28,639,349$123,436,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CELATOR PHARMACEUTICALS INC15089R102Cmn2,246,469$7,121,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
COVIDIEN PLCG2554F113SHS6,226$459,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-14-003157this filing2014-05-15acceptance time not in the bulk data set